XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 2,124 $ 2,289
Accounts receivable-trade, net 911 794
Inventories, net 69 2
Contract assets 344 592
Prepaid expenses and other current assets 433 151
Current assets held for sale   12,866
Total current assets 3,881 16,694
Property, plant and equipment, net 552 598
Advances to and investments in foreign joint ventures 9,980 10,947
Other assets 146 116
Assets held for sale   7,566
Total assets 14,559 35,921
Current liabilities:    
Current portion of long-term note payable   270
Short-term note payable 202 203
Accounts payable and accrued liabilities 2,478 1,719
Liabilities held for sale   13,471
Total current liabilities 2,680 15,663
Long-term note payable   5,524
Deferred compensation 163 213
Total liabilities 2,843 21,400
Commitments and contingencies (Note 13)
Convertible preferred stock:    
Redeemable convertible preferred stock, Series A, net of discount of $502 at December 31, 2018 and $562 at December 31, 2017; $0.001 par value, 1,000,000 shares authorized, issued and outstanding at December 31, 2018 and December 31, 2017 4,498 4,438
Stockholders’ equity:    
Common stock; $0.001 par value, 50,000,000 shares authorized, 9,413,245 and 8,850,532 shares issued and 9,219,270 and 8,669,650 shares outstanding at December 31, 2018 and December 31, 2017 9 9
Treasury stock, at cost 225,608 and 180,882 shares at December 31, 2018 and December 31, 2017 (965) (916)
Additional paid-in capital 14,014 13,455
Accumulated other comprehensive (loss) income (417) 401
Accumulated deficit; including accumulated statutory reserves in equity method investments of $2,809 at both December 31, 2018 and December 31, 2017 (5,423) (2,866)
Total stockholders’ equity 7,218 10,083
Total liabilities, convertible preferred stock and stockholders’ equity $ 14,559 $ 35,921